Zepp Health reported strong Q3 revenue growth of 78.5%, forecasted 40% growth in current quarter. Stock surged 10x. Amazfit brand helping inch back to profitability in wearables market. Undervalued stock with P/S ratio of 3.98. Analysts yet to cover company.

Zepp Health Corp. reported a 78.5% revenue growth in Q3 and forecasts a 40% increase for the current quarter. The company achieved breakeven on an adjusted operating basis for the second consecutive quarter, driven by its Amazfit brand. Despite a 10x stock surge since July, it has lost 40% from its September peak, trading at a P/S ratio of 3.98. Analysts have yet to fully cover the company, with skepticism surrounding the stock's surge, though it appears sustainable.

Is Huami, which says "no" to Xiaomi, a meme or a dark horse?

Huami Technology's revenue grew by 78.5% in the third quarter, and it is expected that the growth rate will slow to about 40% this quarter. The company is gradually emerging from losses after shifting to its own brand Amazfit. Despite the stock price skyrocketing more than nine times since July, it is still considered an undervalued company, with a price-to-sales ratio of 3.98 times, lower than its competitor Garmin's 7.39 times. Huami's brand image needs improvement, and market attention remains low, which is expected to change next year

Zepp Health shares are trading lower. The company reported Q3 financial results.

Zepp Health Achieves Strong Q3 Growth with Amazfit T-Rex 3 Pro Launch

Zepp Health Corporation reported a 78.5% year-over-year revenue increase for Q3 2025, reaching $75.8 million, driven by the launch of the Amazfit T-Rex 3 Pro. The company achieved breakeven in adjusted operating income and anticipates a 38% to 45% revenue growth in Q4. Analysts rate ZEPP stock as a Hold with a $39.00 price target, while Spark's AI Analyst gives it a Neutral rating due to challenging financial performance. Zepp Health specializes in smart wearables and health technology, with a current market cap of $532.6 million.

Zepp Health Corporation reports Q3 revenue of $75.8 million with adjusted operating income of $0.4 million

Zepp Health Corporation reported Q3 2025 revenue of $75.8 million, a 78.5% increase year-over-year. The company had a GAAP operating loss of $0.9 million but an adjusted operating income of $0.4 million, significantly improved from previous losses. Net loss decreased to $1.6 million from $13.3 million last year. Adjusted expenses as a percentage of sales improved to 37.7%. For Q4 2025, revenue is expected to be between $82.0 million and $86.0 million, indicating a projected year-over-year increase of 38% to 45%.